马里巴维尔和瓦尔根西克洛维尔之间的不良事件概况差异:来自FDA不良事件报告系统的发现
Haolin Teng1, Shengnan Zhang1, Jinyu Yu1
1Department of Urology, The First Hospital of Jilin University, Changchun, China.
这项研究比较了maribavir和valganciclovir对细胞巨乳病毒 (CMV) 感染的安全性. 玛丽巴维尔显示出更高的味觉障碍率,而瓦尔甘西克洛维尔与中性质衰竭有关,这两种药物都与死亡有关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床安全 临床安全
- 现实世界的证据 现实世界的证据
背景情况:
- 细胞巨乳病毒 (CMV) 感染是移植后患者的一个重大问题.
- 玛丽巴维尔和瓦尔甘西克洛维尔是CMV管理的关键治疗选择.
- 关于这些药物的长期安全性在大量患者队列中,现实世界的数据有限.
研究的目的:
- 分析和比较maribavir和valganciclovir的不良事件 (AE) 概况.
- 识别明显的安全信号,并为医疗保健提供者提供临床参考点.
- 评估这些CMV药物疗法的现实安全性.
主要方法:
- 使用美国食品和药物管理局不良事件报告系统 (FAERS) 数据库.
- 应用了不成比例分析技术,包括ROR,PRR,BCPNN和MGPS.
- 与马里巴维尔和瓦尔根西克洛维尔相关的目录和量化的副作用.
主要成果:
- 玛丽巴维尔显示出与失味症和味觉障碍的显著关联 (ROR: 65.23).
- 瓦尔甘西克洛维尔特别与中性质衰竭和CMV大肠炎有关 (ROR: 152.26).
- 死亡是马里巴维尔和瓦尔根西克洛维尔的确定的AE,马里巴维尔的中位数AE发病时间为40天,而瓦尔根西克洛维尔的28天.
结论:
- 这项FAERS分析提供了对maribavir和valganciclovir相对安全性的关键见解.
- 这些发现支持加强临床监测和未来研究这些CMV治疗的长期安全性.
- 不同的AE配置文件需要在移植后CMV管理的临床决策中仔细考虑.
更多相关视频
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Clinical Trials: Overview
